Ireland - English - HPRA (Health Products Regulatory Authority)

prographarm laboratories - disopyramide disopyramide - capsule - 100 drop

Ireland - English - HPRA (Health Products Regulatory Authority)

prographarm laboratories - disopyramide - 250 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

prographarm laboratories - propranolol - 160 milligram

Singapore - English - HSA (Health Sciences Authority)

pharmline marketing pte. ltd. - orthopaedics - go-on® is indicated as a viscoelastic supplementation for synovial fluid in the knee. viscosupplementation is recommended in patients with normal weight or moderately overweight with symptomatic mild to moderate knee oa who are not sufficiently improved by nonpharmacological treatment and analgesics/ nsaids or are unable to take analgesics/ nsaids. the actions of the product are lubrication and mechanical support, and it is suited for treatment of the symptoms of osteoarthritis.

European Union - English - EMA (European Medicines Agency)

provepharm sas - methylthioninium chloride - methemoglobinemia - all other therapeutic products - acute symptomatic treatment of medicinal and chemical products- induced methaemoglobinaemia.methylthioninium chloride proveblue is indicated in adults, children and adolescents (aged 0 to 17 years old).

United States - English - NLM (National Library of Medicine)

provepharm inc. - dihydroergotamine mesylate (unii: 81axn7r2qt) (dihydroergotamine - unii:436o5hm03c) - dihydroergotamine mesylate injection, usp is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. there have been a few reports of serious adverse events associated with the coadministration of dihydroergotamine and potent cyp3a4 inhibitors, such as protease inhibitors and macrolide antibiotics, resulting in vasospasm that led to cerebral ischemia and/or ischemia of the extremities. the use of potent cyp3a4 inhibitors (i.e., ritonavir, nelfinavir, indinavir, erythromycin, clarithromycin, troleandomycin, ketoconazole, itraconazole) with dihydroergotamine is, therefore, contraindicated (see warnings, cyp3a4 inhibitors). dihydroergotamine mesylate injection, usp should not be given to patients with ischemic heart disease (e.g., angina pectoris, history of myocardial infarction, or documented silent ischemia) or to patients who have clinical symptoms or findings consistent with coronary artery vasospasm including prinzmetal's variant an

Malta - English - Medicines Authority

rottapharm s.p.a galleria unione, 5-20122 milan, italy - glucosamine sulfate, sodium chloride - hard capsule - glucosamine sulfate 250 mg sodium chloride 64 mg - antiinflammatory and antirheumatic products

Ireland - English - HPRA (Health Products Regulatory Authority)

rottapharm ltd - glyceryl trinitrate - transdermal patch - 10 milligram(s)/24 hours - organic nitrates; glyceryl trinitrate

Ireland - English - HPRA (Health Products Regulatory Authority)

rottapharm ltd - glyceryl trinitrate - transdermal patch - 5 milligram(s)/24 hours - organic nitrates; glyceryl trinitrate

Ireland - English - HPRA (Health Products Regulatory Authority)

rottapharm ltd - glyceryl trinitrate - transdermal patch - 15 milligram(s)/24 hours - organic nitrates; glyceryl trinitrate